Concepedia

A prospective head-to-head comparison of 68 Ga-NOTA-3P-TATE-RGD and 68 Ga-DOTATATE in patients with gastroenteropancreatic neuroendocrine tumours

Yuanyuan Jiang, Qingxing Liu, Guochang Wang, Huimin Sui, Rongxi Wang, Jiarou Wang, Zhaohui Zhu

European Journal of Nuclear Medicine and Molecular Imaging · 2022 · 11 citations · 29 references

DOI

Concepts

References

29

Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors

Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin et al. · New England Journal of Medicine · 2017 · 3.2K citations · Full text

, , +17

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

Michael Gabriel, Clemens Decristoforo, Dorota Kendler et al. · Journal of Nuclear Medicine · 2007 · 1K citations · Full text

, , +17

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogs

Dik J. Kwekkeboom, Eric P. Krenning, Rachida Lebtahi et al. · Neuroendocrinology · 2009 · 349 citations · Full text

, , +17

<sup>68</sup>Ga-DOTATOC Versus <sup>68</sup>Ga-DOTATATE PET/CT in Functional Imaging of Neuroendocrine Tumors

Thorsten D. Poeppel, Ina Binse, Stephan Petersenn et al. · Journal of Nuclear Medicine · 2011 · 339 citations · Full text

, , +17

Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance

David LH Chan, Nick Pavlakis, Geoffrey Schembri et al. · Theranostics · 2017 · 286 citations · Full text

, , +17